Table of contents

Clinical and epidemiological research

• Extended report: Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose (9 September, 2015) Free

  Catherine L Hill, Lynette M March, Dawn Aitken, Susan E Lester, Ruth Battersby, Kristen Hynes, Tanya Fedorova, Susanna M Proudman, Michael James, Leslie G Cleland, Graeme Jones
• Extended report: Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up (30 December, 2014)

  Chi Chiu Mok, King Yee Ying, Cheuk Wan Yim, Yui Pong Siu, Ka Hang Tong, Chi Hung To, Woon Leung Ng
• Extended report: Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib (14 January, 2015)

  Marc C Hochberg, Johanne Martel-Pelletier, Jordi Monfort, Ingrid Möller, Juan Ramón Castillo, Nigel Arden, Francis Berenbaum, Francisco J Blanco, Philip G Conaghan, Gema Doménech, Yves Henrotin, Thomas Pap, Pascal Richette, Allen Sawitzke, Patrick du Souich, Jean-Pierre Pelletier
• Extended report: Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study (6 February, 2015)

  Judith Haschka, Matthias Englbrecht, Axel J Hueber, Bernhard Manger, Arnd Kleyer, Michaela Reiser, Stephanie Finzel, Hans-Peter Tony, Stefan Kleinert, Martin Feuchtenberger, Martin Fleck, Karin Manger, Wolfgang Ochs, Matthias Schmitt-Haendle, Joerg Wendler, Florian Schuch, Monika Ronneberger, Hanns-Martin Lorenz, Hubert Nuesslein, Rieke Alten, Winfried Demary, Joerg Henes, Georg Schett, Juergen Rech
• Extended report: Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis (14 April, 2015)

  Ronald F van Vollenhoven, Mikkel Østergaard, Marjatta Leirisalo-Repo, Till Uhlig, Marita Jansson, Esbjörn Larsson, Fiona Brock, Karin Franck-Larsson
• Extended report:

  Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)

  (23 June, 2015)

  Bruno Fautrel, Thao Pham, Toni Alfaiate, Frédérique Gandjbakhch, Violaine Foltz, Jacques Morel, Emmanuelle Dernis, Philippe Gaudin, Olivier Brocq, Elisabeth Solau-Gervais, Jean-Marie Berthelot, Jean-Charles Balblanc, Xavier Mariette, Florence Tubach
• Extended report: Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA) (8 June, 2015)

  Gerd R Burmester, Andrea Rubbert-Roth, Alain Cantagrel, Stephen Hall, Piotr Leszczynski, Daniel Feldman, Madura J Rangaraj, Georgia Roane, Charles Ludivico, Min Bao, Lucy Rowell, Claire Davies, Eduardo F Mysler
• Extended report: The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression (2 July, 2015)

  Tatsuya Atsumi, Kazuhiko Yamamoto, Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Yoshiya Tanaka, Katsumi Eguchi, Akira Watanabe, Hideki Origasa, Shinsuke Yasuda, Yuji Yamanishi, Yasuhiko Kita, Tsukasa Matsubara, Masahiro Iwamoto, Toshiharu Shoji, Toshiyuki Okada, Désirée van der Heijde, Nobuyuki Miyasaka, Takao Koike
• Extended report: Synovial tissue volume: a treatment target in knee osteoarthritis (OA) (26 June, 2015)

  Terence W O'Neill, Matthew J Parkes, Nasimah Maricar, Elizabeth J Marjanovic, Richard Hodgson, Andrew D Gait, Timothy F Cootes, Charles E Hutchinson, David T Felson
• Extended report: Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study (2 October, 2014)

  Young Hee Rho, Na Lu, Christine E Peloquin, Ada Man, Yanyan Zhu, Yuqing Zhang, Hyon K Choi
• Extended report: A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study (27 August, 2014)

  Jakub Závada, Michal Uher, Katarína Sisol, Šárka Forejtová, Kateřina Jarošová, Heřman Mann, Jiří Vencovský, Karel Pavelka
• Extended report: Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study (27 August, 2014)

  Jérôme Avouac, Ulrich A Walker, Eric Hachulla, Gabriela Riemekasten, Giovanna Cuomo, Patricia E Carreira, Paola Caramaschi, Lidia P Ananieva, Marco Matucci-Cerinic, Laszlo Czirjak, Christopher Denton, Ulf Müller Ladner, Yannick Allanore, the EUSTAR collaborators*
• Extended report: Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study (5 September, 2014)

  Erin C Carruthers, Hyon K Choi, Eric C Sayre, J Antonio Aviña-Zubieta
• Extended report: MRI findings predict radiographic progression and development of erosions in hand osteoarthritis (9 September, 2014)

  Ida K Haugen, Barbara Slatkowsky-Christensen, Pernille Bøyesen, Sølve Sesseng, Désirée van der Heijde, Tore K Kvien
• Extended report: Twenty-eight loci that influence serum urate levels: analysis of association with gout (3 September, 2014)

  A J Phipps-Green, M E Merriman, R Topless, S Altaf, G W Montgomery, C Franklin, G T Jones, A M van Rij, D White, L K Stamp, N Dalbeth, T R Merriman
• Extended report: Psoriatic arthritis treatment and the risk of herpes zoster (26 September, 2014)

  D Zisman, H Bitterman, G Shalom, I Feldhamer, D Comanesther, E Batat, S Greenberg-Dotan, S Cohen, A D Cohen
• Extended report: The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012 (29 September, 2014)

  Frances Rees, Michael Doherty, Matthew Grainge, Graham Davenport, Peter Lanyon, Weiya Zhang
• Extended report: Patient preferences for psychological support in inflammatory arthritis: a multicentre survey (26 September, 2014)

  Emma Dures, Celia Almeida, Judy Caesley, Alice Peterson, Nicholas Ambler, Marianne Morris, Jon Pollock, Sarah Hewlett
• Extended report: The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study (29 September, 2014)

  J Antonio Aviña-Zubieta, Vidula M Bhole, Neda Amiri, Eric C Sayre, Hyon K Choi
• Extended report: Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype (26 September, 2014)

  Muhammad Haroon, Robert Winchester, Jon T Giles, Eric Heffernan, Oliver FitzGerald
• Extended report: A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study (23 October, 2014)

  Muriel Elhai, Jérôme Avouac, Ulrich A Walker, Marco Matucci-Cerinic, Gabriela Riemekasten, Paolo Airò, Eric Hachulla, Gabriele Valentini, Patricia E Carreira, Franco Cozzi, Alexandra Balbir Gurman, Yolanda Braun-Moscovici, Nemanja Damjanov, Lidia P Ananieva, Raffaella Scorza, Sergio Jimenez, Joanna Busquets, Mengtao Li, Ulf Müller-Ladner, André Kahan, Oliver Distler, Yannick Allanore, EUSTAR co-authors
• Extended report: MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study (29 October, 2014)

  Charles Peterfy, Paul Emery, Paul P Tak, Mikkel Østergaard, Julie DiCarlo, Kati Otsa, Federico Navarro Sarabia, Karel Pavelka, Marie-Agnes Bagnard, Lykke Hinsch Gylvin, Corrado Bernasconi, Annarita Gabriele
• Extended report: Performance of classification criteria for gout in early and established disease (28 October, 2014)

  William J Taylor, Jaap Fransen, Nicola Dalbeth, Tuhina Neogi, H Ralph Schumacher, Melanie Brown, Worawit Louthrenoo, Janitzia Vazquez-Mellado, Maxim Eliseev, Geraldine McCarthy, Lisa K Stamp, Fernando Perez-Ruiz, Francisca Sivera, Hang-Korng Ea, Martijn Gerritsen, Carlo Scire, Lorenzo Cavagna, Chingtsai Lin, Yin-Yi Chou, Anne-Kathrin Tausche, Geraldo da Rocha Castelar-Pinheiro, Matthijs Janssen, Jiunn-Horng Chen, Ole Slot, Marco Cimmino, Till Uhlig, Tim L Jansen
• Extended report: Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden (12 December, 2014)

  Thomas Frisell, Karin Hellgren, Lars Alfredsson, Soumya Raychaudhuri, Lars Klareskog, Johan Askling
• Extended report: Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis (31 October, 2014)

  Anne M Selvaag, Hanne A Aulie, Vibke Lilleby, Berit Flatø
• Extended report: A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE) (2 June, 2015)

  Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, Jacqueline M McBride, Michael J Townsend, Xiaohui Wei, John C Davis, William P Kennedy
• Extended report: Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study (31 October, 2014)

  Ivette Essers, Carmen Stolwijk, Annelies Boonen, Marie L De Bruin, Marloes T Bazelier, Frank de Vries, Astrid van Tubergen
• Extended report: Comorbidities in patients with gout prior to and following diagnosis: case-control study (14 November, 2014)

  Chang-Fu Kuo, Matthew J Grainge, Christian Mallen, Weiya Zhang, Michael Doherty